CELEX: 62018TN0643
Language: en
Date: 2018-10-29 00:00:00
Title: Case T-643/18: Action brought on 29 October 2018 — August Wolff v EUIPO — Faes Farma (DermoFaes)

14.1.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 16/52
            
         
      Action brought on 29 October 2018 — August Wolff v EUIPO — Faes Farma (DermoFaes)
      (Case T-643/18)
      (2019/C 16/63)
      Language of the case: English
      
         Parties
      
      
         Applicant: Dr. August Wolff GmbH & Co. KG Arzneimittel (Bielefeld, Germany) (represented by: A. Thünken, lawyer)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: Faes Farma, SA (Lamiaco-Leioa, Spain)
      
         Details of the proceedings before EUIPO
      
      
         Applicant of the trade mark at issue: Other party to the proceedings before the Board of Appeal
      
         Trade mark at issue: Application for European Union word mark DermoFaes — Application for registration No 15 069 289
      
         Procedure before EUIPO: Opposition proceedings
      
         Contested decision: Decision of the Second Board of Appeal of EUIPO of 14 June 2018 in Case R 1842/2017-2
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  annul the contested decision;
               
            
                  —
               
               
                  uphold the opposition and reject the contested application;
               
            
                  —
               
               
                  order EUIPO and, as the case may be, the intervener to bear the costs of the proceedings and the costs incurred by proceedings before EUIPO.
               
            
         Plea in law
      
      
                  —
               
               
                  Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.